FILE — The Biogen Inc., headquarters is shown March 11, 2020, in Cambridge, Mass. Biogen has agreed, Monday, Sept. 27, 2022, to pay $900 million to resolve allegations that it violated federal law by paying kickbacks to doctors to persuade them to prescribe its multiple sclerosis drugs, federal prosecutors said. (AP Photo/Steven Senne, File)
